Biodesix, Inc. BDSX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$7.79M+29.8% | -$3.98M+51.8% | -$8.72M+15.0% | -$11.47M-6.1% | -$11.1M+18.5% | ||
| $1.4M-3.1% | $1.39M-4.3% | $1.41M-5.8% | $1.44M+1.7% | $1.44M+1.4% | ||
| $1.12M+14.7% | $1.08M-15.0% | $1.05M-30.5% | $1.04M-14.7% | $972K-63.2% | ||
| $24K-76.2% | $71K-83.6% | $0-100% | $8K-91.2% | $101K-21.7% | ||
| $488K+154% | —— | $5.22M— | -$181K-156% | -$904K-139% | ||
| -$2.34M-20.9% | $974K-42.5% | $486K— | $2.34M— | -$1.94M-57.1% | ||
| -$19K-26.7% | $0+100% | $125K+438% | $20K+159% | -$15K-168% | ||
| -$766K-1,023% | —— | $2.13M+953% | -$197K-282% | $83K+324% | ||
| $5K-93.2% | $1K-99.0% | $7K— | $26K-61.2% | $73K+7.4% | ||
| -$341K-1,794% | -$315K-1,055% | -$224K-705% | -$232K-327% | -$18K-103% | ||
| $1.37M+735% | $592K— | -$16K— | -$103K+93.4% | -$215K-151% | ||
| -$10.17M-18.2% | $0+100% | -$8.88M+16.8% | -$6.57M+64.6% | -$8.6M+43.8% | ||
| $81K+9.5% | $86K-89.7% | $48K-79.2% | $51K-97.4% | $74K-68.4% | ||
| -$144K-5.1% | -$104K+88.2% | -$67K+76.6% | -$95K+95.2% | -$137K+49.8% | ||
| $5K-28.6% | $5K-61.5% | $4K-69.2% | $5K-58.3% | $7K-46.2% | ||
| $17.21M— | $2.32M— | —— | —— | —— | ||
| -$158K+20.2% | -$262K-55.0% | -$167K-32.5% | -$190K-138% | -$198K-183% | ||
| $28K+155% | $0-100% | $3K+200% | $16K-15.8% | $11K-38.9% | ||
| $16.9M+17,320% | $1.71M— | $4.82M+3,249% | $9.79M-80.9% | $97K-87.7% | ||
| $6.59M+176% | —— | -$4.12M+61.9% | —— | -$8.64M+41.6% | ||
| $1.62M+17.7% | $1.71M-33.7% | $1.75M-11.5% | $1.56M+56.7% | $1.38M-6.5% | ||
| $332K+7.4% | $333K+12.9% | $332K+300% | $330K-67.6% | $309K-71.0% | ||
| -$341K-1,794% | -$315K-1,055% | -$224K-705% | -$232K-327% | -$18K-103% | ||
| $1.37M+735% | $592K— | -$16K— | -$103K+93.4% | -$215K-151% | ||
| $20K— | $28K+1,300% | $10K+25.0% | —— | —— | ||
| $19K+154% | —— | —— | —— | -$35K— | ||
| $24K-76.2% | $71K-83.6% | $0-100% | $8K-91.2% | $101K-21.7% | ||
| $63K0.0% | $18K-60.0% | $19K-65.5% | $44K-38.0% | $63K+61.5% | ||
| $481K— | $344K— | —— | —— | —— | ||
| $28K+155% | $0-100% | $3K+200% | $16K-15.8% | $11K-38.9% | ||
| $354K+13.1% | —— | $184K-46.2% | —— | $313K+11.0% | ||
| -$158K+20.2% | -$262K-55.0% | -$167K-32.5% | -$190K-138% | -$198K-183% | ||
| —— | —— | —— | $200K— | $378K— | ||
| -$766K-1,023% | —— | $2.13M+953% | -$197K-282% | $83K+324% | ||
| -$341K-1,794% | -$315K-1,055% | -$224K-705% | -$232K-327% | -$18K-103% | ||
| —— | $859K+77.1% | $414K+120% | $0— | $172K— | ||
| $59K+31.1% | —— | $687K— | —— | $45K-86.7% | ||
| —— | —— | —— | —— | $8K-38.5% | ||
| $64K+3,557% | $1.75K— | $1.75K— | $1.75K— | $1.75K-99.4% | ||
| $1.25M— | —— | —— | —— | —— | ||
| -$10.25M-18.1% | $0+100% | -$8.93M+18.1% | -$6.62M+67.7% | -$8.68M+44.2% | ||
| -$10.25M-18.1% | $0+100% | -$8.93M+18.1% | -$6.62M+67.7% | -$8.68M+44.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Biodesix, Inc. generate?
- Biodesix, Inc. (BDSX) generated -$25.6M in operating cash flow over the trailing twelve months.
- What is Biodesix, Inc.'s free cash flow?
- After $266.0K of capital expenditures, Biodesix, Inc.'s free cash flow was -$25.8M over the trailing twelve months, up 42.7% year over year.
- Where does Biodesix, Inc.'s cash flow data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
